# SciSpace vs Unlearn.AI

SciSpace records 4,464,111 monthly visits with +8.6% month-over-month growth and Freemium pricing. Unlearn.AI records 17,107 monthly visits with -32.5% growth and Contact for Pricing pricing.

| Metric | [SciSpace](https://openaitools.app/tool/scispace) | [Unlearn.AI](https://openaitools.app/tool/unlearn-ai) |
| :--- | :--- | :--- |
| Website URL | https://scispace.com | https://unlearn.ai |
| Categories | AI Chatbot, AI Research Tool, AI PDF Summarizer, AI Copilot | AI Healthcare, AI Research Tool, AI Predictions, AI Models |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 4,464,111 | 17,107 |
| MoM Growth Rate | +8.6% | -32.5% |
| Primary Market | United States | United States |
| Direct Visits | 1,315,134 | 7,493 |
| Review Score | 4.6 | 4.4 |
| Saved Count | 54 | 1 |
| Supported Platforms | Website | Website |

## SciSpace

SciSpace began as a typesetting and paper-formatting service called Typeset and has since grown into a broad AI research platform. Its core promise is that a researcher can move from finding a paper to understanding it to citing and writing about it without leaving one workspace. The platform indexes scholarly content from sources such as Google Scholar, PubMed and arXiv, and layers AI agents on top for reading, extracting data and synthesis.

The signature capability is conversational reading: you upload or open a PDF, then ask questions, highlight confusing sentences for plain-language explanation, or request structured summaries of methods, results and limitations. Around that sit task-specific tools — Literature Review, AI Writer, Paraphraser, Citation Generator, AI Detector, AI Humanizer, Extract Data and a Plagiarism Checker — plus a Chrome extension that adds the same assistant on top of publisher pages and a mobile app for reading on the go.

Access follows a freemium model: exploring and limited usage are free, while paid Premium, Advanced, Max and Enterprise plans raise model quality, credit limits and parallel agent capacity. The company is registered as PubGenius Inc. in Milpitas, California, and markets the product to individual researchers as well as universities and enterprises with SSO and admin controls.

**Pricing & Plans:** Freemium. A free tier with limited usage sits alongside paid Premium (~$12/month billed annually), Advanced (~$70/month) and Max (~$160/month) plans; monthly billing is higher. Enterprise pricing is custom. All plans advertise a 24-hour money-back guarantee, and annual billing carries a discount.

- **Chat with PDF:** Open or upload a paper and ask questions, get plain-language explanations of highlighted passages, and pull out methods, results and limitations conversationally.
- **Literature Review and paper search:** Search a large scholarly index spanning Google Scholar, PubMed and arXiv, then generate structured literature reviews and related-work sections from what you find.
- **Writing, paraphrasing and citations:** An AI Writer for drafts, a paraphraser for academic tone, and a citation generator that formats references in popular styles.
- **Extract Data and AI Detector:** Turn tables and results in a paper into structured data, and check whether a manuscript reads as AI-generated with a built-in detector.
- **Chrome extension and mobile app:** Use the same assistant on top of publisher sites and PDF pages via the browser extension, or read and query papers from the mobile app.

**Strengths:** Combines paper discovery, reading, writing and citation tools in one place instead of five separate subscriptions; Conversational explanations of difficult passages are genuinely useful for non-native English readers and cross-disciplinary work; Covers widely used scholarly sources such as Google Scholar, PubMed and arXiv; Free tier plus a Chrome extension make it easy to evaluate before paying

**Limitations:** Credit-based limits can be confusing, and heavy users report hitting caps on the cheaper plans; Model access varies by tier, so the cheapest paid plan does not get the strongest reasoning models; AI-generated reviews and paraphrases still need careful human checking for accuracy and citation integrity

[Profile (Markdown)](https://openaitools.app/tool/scispace.md)

## Unlearn.AI

Unlearn.AI works with biopharma sponsors and clinical research teams at three points in a trial's lifecycle: before the protocol is finalized, while the study is running, and after readout. In design, teams model the patients they expect to enroll and pressure-test sample size, eligibility criteria, endpoints, and comparators before locking the protocol. The company's PROCOVA method — described as EMA-qualified and FDA-supported — applies twin-based covariate adjustment to reduce sample size in randomized controlled trials while holding statistical power, or to increase power without adding patients.

Mid-study, Unlearn supports pre-specified twin-based analyses that tighten interim estimates without enrolling anyone new, and lets teams re-run design scenarios when new evidence — a competitor readout, a fresh publication, or blinded data drifting from assumptions — changes the picture. After a study reads out, digital twins are used to contextualize population, endpoints, and variability, improving sensitivity across endpoints and helping teams re-evaluate historical trial data with regulatory-aligned methods.

Unlearn publishes concrete case outcomes: a 20% sample-size reduction built into a Phase 1/2 design with roughly $2M in savings, a 33% smaller control arm and four-plus months of enrollment time saved in a re-analysis of completed Phase 3 trials from a top-5 global sponsor, and a completed Phase 3 ALS trial re-analyzed to keep full power with 92 fewer participants. The company partners with sponsors including Trace Neuroscience, QurAlis, Acumen Pharmaceuticals, SOLA Biosciences, VectorY Therapeutics, and CHDI Foundation, and states it works with top global pharma companies. Unlearn does not publish list pricing; engagements are scoped through direct contact.

**Pricing & Plans:** Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

- **AI-generated patient digital twins:** Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
- **PROCOVA design and analysis method:** A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
- **Trial design scenario modeling:** Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
- **Interim and readout analysis support:** Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.
- **Externally controlled study design:** Design single-arm and externally controlled studies where randomization is not an option, selecting eligibility criteria that give open-label studies the best chance of a clear readout.

**Strengths:** Digital twins are generated from data already collected, so no extra patients are required to gain information; Publicly reported, quantified outcomes — sample-size reductions, cost savings, and enrollment time saved — rather than only qualitative claims; Covers the whole trial lifecycle: design, interim, and readout, not just one decision point; Named collaborations with biotech and pharma sponsors, plus regulatory-aligned methodology

**Limitations:** Pricing is not published, so budgeting requires a direct sales conversation; The value proposition depends on regulatory acceptance of twin-based methods, which varies by agency and indication; Best suited to sponsors with existing clinical data and statistical teams; not a self-serve tool; Public metrics come from specific studies and may not transfer directly to other indications

[Profile (Markdown)](https://openaitools.app/tool/unlearn-ai.md)

## Frequently Asked Questions

### How do SciSpace and Unlearn.AI compare in monthly traffic?

SciSpace has 4,464,111 monthly visits, while Unlearn.AI has 17,107. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

SciSpace has a month-over-month growth rate of +8.6%; Unlearn.AI has -32.5%.

### How does pricing compare?

SciSpace: Freemium. Freemium. A free tier with limited usage sits alongside paid Premium (~$12/month billed annually), Advanced (~$70/month) and Max (~$160/month) plans; monthly billing is higher. Enterprise pricing is custom. All plans advertise a 24-hour money-back guarantee, and annual billing carries a discount. Unlearn.AI: Contact for Pricing. Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [ChatGPT](https://openaitools.app/tool/chatgpt-4) | 6,048,022,723 | +2.2% | Freemium | Offers broad general reasoning and document upload capabilities, but lacks specialized academic indexing and citation databases. | [.md](https://openaitools.app/tool/chatgpt-4.md) |
| 2 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | Provides a massive free index of scholarly literature with citation graphs, but lacks built-in interactive paper reading assistants. | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 3 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | Provides evidence-based answers extracted directly from peer-reviewed papers, though less of an all-in-one reading workspace. | [.md](https://openaitools.app/tool/consensus.md) |
| 4 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | Stronger automated data extraction and systematic review synthesis, but less focused on interactive PDF annotation than SciSpace. | [.md](https://openaitools.app/tool/elicit.md) |
| 5 | [Jenni](https://openaitools.app/tool/jenni) | 1,498,133 | +5.2% | Freemium | Focuses heavily on assisted academic drafting and autocomplete, whereas SciSpace centers more on reading and analysis. | [.md](https://openaitools.app/tool/jenni.md) |
| 6 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | Excels at tracking citation contexts and how papers cite each other, but has less robust general PDF chat features. | [.md](https://openaitools.app/tool/scite.md) |
| 7 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 8 | [Paperguide](https://openaitools.app/tool/paperguide) | 371,972 | -2.9% | Freemium | Streamlines literature searches and reference management like SciSpace, but with a distinct citation workflow. | [.md](https://openaitools.app/tool/paperguide.md) |
| 9 | [Upheal](https://openaitools.app/tool/upheal-io) | 347,782 | -2.1% | Freemium, Free Trial, Contact for Pricing | AI therapy notes and an AI-native EHR built for mental health professionals. | [.md](https://openaitools.app/tool/upheal-io.md) |
| 10 | [ResearchPal](https://openaitools.app/tool/researchpal) | 55,231 | -5.2% | Freemium | Searches academic sources and generates literature reviews, but lacks some of SciSpace's advanced collaborative workspace features. | [.md](https://openaitools.app/tool/researchpal.md) |

---
Source: https://openaitools.app/compare/scispace-vs-unlearn-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
